Eva Versteijne
About
Eva Versteijne is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Eva Versteijne has authored 32 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 14 papers in Surgery. Recurrent topics in Eva Versteijne's work include Pancreatic and Hepatic Oncology Research (16 papers), Advanced Radiotherapy Techniques (9 papers) and Neuroendocrine Tumor Research Advances (6 papers). Eva Versteijne is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Advanced Radiotherapy Techniques (9 papers) and Neuroendocrine Tumor Research Advances (6 papers). Eva Versteijne collaborates with scholars based in Netherlands, United Kingdom and Italy. Eva Versteijne's co-authors include Geertjan van Tienhoven, Casper H.J. van Eijck, Olivier R. Busch, Marc G. Besselink, Johanna W. Wilmink, Bas Groot Koerkamp, Joost G. Daams, C. Rasch, Jantien A. Vogel and Hanneke W.M. van Laarhoven and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and International Journal of Radiation Oncology*Biology*Physics.
In The Last Decade
Eva Versteijne
29 papers receiving 887 citations
Hit Papers
Peers
Eva Versteijne
Evan Wuthrick United States
Claudio V. Sole Spain
Ralph R. Dobelbower United States
Shuichi Kanamori Japan
Yi‐Jen Chen United States
Makoto Shinoto Japan
Jean-Claude M. Rwigema United States
P. Fenoglietto France
D. Lerouge France
David S. Parda United States
Citations per year, relative to Eva Versteijne Eva Versteijne (= 1×)
peers
Evan Wuthrick
Countries citing papers authored by Eva Versteijne
Since
Specialization
Citations
This map shows the geographic impact of Eva Versteijne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Versteijne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Versteijne more than expected).
Fields of papers citing papers by Eva Versteijne
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eva Versteijne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Versteijne. The network helps show where Eva Versteijne may publish in the future.
Co-authorship network of co-authors of Eva Versteijne
This figure shows the co-authorship network connecting the top 25 collaborators of Eva Versteijne. A scholar is included among the top collaborators of Eva Versteijne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Versteijne. Eva Versteijne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Verbakel, Wilko F.A.R., et al.. (2025). Routine Use of Single Visit Online Adaptive Cone Beam Computed Tomography Guided Sim-Free Palliative Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 122(4). 1035–1044.
2.
Kesteren, Z. van, Michael J. Parkes, Markus F. Stevens, et al.. (2024). Noninvasive Mechanical Ventilation Is a Promising Way to Improve Lung Cancer Radiation Therapy. Advances in Radiation Oncology. 10(2). 101679–101679.
3.
Sprangers, Mirjam A. G., Konstantinos Pateras, A. Bruynzeel, et al.. (2023). Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial. International Journal of Radiation Oncology*Biology*Physics. 118(2). 352–361.
4.
Lagerwaard, Frank J., Susan van Dieren, Martijn R. Meijerink, et al.. (2023). Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort. Frontiers in Oncology. 13. 1149961–1149961.
5.
Ee, Thomas van, Arantza Fariña Sarasqueta, Johanna W. Wilmink, et al.. (2023). The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer. Journal of Cancer Research and Clinical Oncology. 149(16). 14731–14743.
6.
Wilmink, Johanna W., Mirjam A. G. Sprangers, M. Jacobs, et al.. (2023). OC-0100 Short course radiation improves pain from pancreatic cancer: A prospective phase II study (NTR5143). Radiotherapy and Oncology. 182. S61–S62.
7.
Versteijne, Eva, Suresh Senan, M. Admiraal, et al.. (2023). Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS study. Radiotherapy and Oncology. 182. 109538–109538.
8.
Besselink, Marc G., Casper H.J. van Eijck, Martijn Intven, et al.. (2022). Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design. BMC Cancer. 22(1). 1363–1363.
9.
Versteijne, Eva, Ignace H. J. T. de Hingh, Marjolein Y.V. Homs, et al.. (2022). Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?. Frontiers in Oncology. 11. 744161–744161.
10.
Versteijne, Eva, Bert A. Bonsing, J. Sven D. Mieog, et al.. (2022). The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial. European Journal of Surgical Oncology. 49(4). 811–817.
11.
Versteijne, Eva, Jacob L. van Dam, Mustafa Suker, et al.. (2021). Improved Overall Survival in Pancreatic Cancer with Preoperative Chemoradiotherapy: Long-term Results of the PREOPANC Trial. HPB. 23. S672–S673.
12.
Eijck, Casper H.J. van, Eva Versteijne, Mustafa Suker, et al.. (2021). Preoperative chemoradiotherapy to improve overall survival in pancreatic cancer: Long-term results of the multicenter randomized phase III PREOPANC trial.. Journal of Clinical Oncology. 39(15_suppl). 4016–4016.
13.
Giovinazzo, Francesco, Fiammetta Soggiu, Jin‐Young Jang, et al.. (2020). Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data. Frontiers in Oncology. 10.
14.
Suker, Mustafa, Eva Versteijne, Bert A. Bonsing, et al.. (2020). Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial). Annals of Surgery. 275(5). 979–984.
15.
Versteijne, Eva, E. Lens, Astrid van der Horst, et al.. (2017). Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer. Strahlentherapie und Onkologie. 193(8). 630–638.
16.
Versteijne, Eva, Oliver J. Gurney‐Champion, Astrid van der Horst, et al.. (2017). Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study. Radiation Oncology. 12(1). 58–58.
17.
Gurney‐Champion, Oliver J., Eva Versteijne, Astrid van der Horst, et al.. (2017). Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study. Acta Oncologica. 56(7). 923–930.
18.
Jeene, Paul M., Eva Versteijne, Mark I. van Berge Henegouwen, et al.. (2016). Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment. Diseases of the Esophagus. 30(2). 1–5.
19.
Jeene, Paul M., Eva Versteijne, Mark I. van Berge Henegouwen, et al.. (2016). Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation. Acta Oncologica. 56(1). 33–38.
20.
Lens, E., Astrid van der Horst, Eva Versteijne, Geertjan van Tienhoven, & Arjan Bel. (2015). Dosimetric Advantages of Midventilation Compared With Internal Target Volume for Radiation Therapy of Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 92(3). 675–682.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Evan Wuthrick Breakdown of academic impact, for papers by Claudio V. Sole Breakdown of academic impact, for papers by Ralph R. Dobelbower Breakdown of academic impact, for papers by Shuichi Kanamori Breakdown of academic impact, for papers by Yi‐Jen Chen Breakdown of academic impact, for papers by Makoto Shinoto Breakdown of academic impact, for papers by Jean-Claude M. Rwigema Breakdown of academic impact, for papers by P. Fenoglietto Breakdown of academic impact, for papers by D. Lerouge Breakdown of academic impact, for papers by David S. Parda